Yahoo Web Search

Search results

  1. Jun 24, 2021 · Tony Cataldo, the CEO of GT Biopharma, a clinical stage immuno-oncology company, will speak at the Global Family Office Investment Summit in Monaco in June 2021. GT Biopharma develops TriKE™ protein biologic products for cancer treatment.

  2. Tony Cataldo came on the Investment Spotlight Series to speak with Chris Versace and Jay Coulter about GT Biopharma's outlook. Tony's Biography (From Their W...

    • 52 min
    • 3.1K
    • Financial Advisor TV™
  3. Patrick Tsang interviews Anthony Cataldo, the CEO of GT Biopharma, a clinical-stage immuno-oncology company developing innovative therapies based on proprietary NK cell engager (TriKE®)...

    • 16 min
    • 20.9K
    • Anything is Possible Podcast with Patrick Tsang
  4. Aug 13, 2021 · GT Biopharma, Inc. ( NASDAQ: GTBP) Q2 2021 Earnings Conference Call August 13, 2021 8:30 AM ET. Company Participants. David Castaneda - Investor Relations. Tony Cataldo - Chairman & Chief ...

  5. Jun 24, 2021 · Tony Cataldo, the CEO of GT Biopharma, a clinical stage immuno-oncology company, will speak at the Global Family Office Investment Summit in Monaco in June 2021. GT Biopharma develops TriKE™, a protein biologic technology platform that enhances natural killer cells' cancer killing abilities.

  6. Mr. Breen was also a director and major shareholder of an affiliate of Insinger de Beaufort Holdings S.A. Mr. Breen is a former senior equity partner in the 400+ partner and 50+ office law firm of Clyde & Co, whose head office is based in the City of London, England.

  7. Jul 13, 2021 · Anthony J. Cataldo, CEO, GT Biopharma, USA. MONTE CARLO, MONACO – (July 2, 2021) – The most powerful and influential investors representing elite family offices travelled from around the...

    • 6 min
    • 480
    • The CEO Magazine